{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:20:16Z","timestamp":1785788416535,"version":"3.56.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1097\/01.mph.0000139414.66455.a4","type":"journal-article","created":{"date-parts":[[2004,9,8]],"date-time":"2004-09-08T15:52:07Z","timestamp":1094658727000},"page":"549-552","source":"Crossref","is-referenced-by-count":12,"title":["Ataxia and Secretory Diarrhea: Two Unusual Paraneoplastic Syndromes Occurring Concurrently in the Same Patient With Ganglioneuroblastoma"],"prefix":"10.1097","volume":"26","author":[{"given":"Benjamin","family":"Gesundheit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Ted","family":"Gerstle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila S","family":"Weitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S. L","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210227","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00043426-200007000-00007","article-title":"Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.","volume":"22","author":"Antunes","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"R2-4-20210227","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1067\/mpd.2001.118200","article-title":"Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.","volume":"139","author":"Hayward","year":"2001","journal-title":"J Pediatr"},{"key":"R3-4-20210227","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mpo.1138","article-title":"Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodiesa report from the Childrens Cancer Group Study.","volume":"36","author":"Rudnick","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R4-4-20210227","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1200\/JCO.1989.7.2.236","article-title":"Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.","volume":"7","author":"Matthay","year":"1989","journal-title":"J Clin Oncol"},{"key":"R5-4-20210227","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.25.3.271","article-title":"Myoclonic encephalopathy of infants.","volume":"25","author":"Kinsbourne","year":"1962","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-4-20210227","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1056\/NEJM196808292790907","article-title":"Opsoclonus and occult neuroblastoma.","volume":"279","author":"Solomon","year":"1968","journal-title":"N Engl J Med"},{"key":"R7-4-20210227","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mpo.1139","article-title":"Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic featuresa report from the Childrens Cancer Group.","volume":"36","author":"Cooper","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R8-4-20210227","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E","article-title":"Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.","volume":"28","author":"Russo","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"R9-4-20210227","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-3476(95)70322-5","article-title":"Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G.","volume":"127","author":"Petruzzi","year":"1995","journal-title":"J Pediatr"},{"key":"R10-4-20210227","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9343(58)90075-5","article-title":"Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia.","volume":"25","author":"Verner","year":"1958","journal-title":"JAMA"},{"key":"R11-4-20210227","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1542\/peds.23.5.951","article-title":"Occurrence of chronic diarrhea in three patients with ganglioneuromas.","volume":"23","author":"Green","year":"1959","journal-title":"Pediatrics"},{"key":"R12-4-20210227","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0143-4179(93)90027-8","article-title":"VIP potentiates retinoic-acid effect on tissue transglutaminase activity in human neuroblastoma, the SK-N-SH cells.","volume":"24","author":"Goossens","year":"1993","journal-title":"Neuropeptides"},{"key":"R13-4-20210227","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/1097-0142(19950915)76:6<1086::AID-CNCR2820760625>3.0.CO;2-8","article-title":"Trk A gene expression in neuroblastoma: the clinical significance of an immunohistochemical study.","volume":"76","author":"Tanaka","year":"1995","journal-title":"Cancer"},{"key":"R14-4-20210227","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2000-9677","article-title":"Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.","volume":"212","author":"Eggert","year":"2000","journal-title":"Klin Paediatr"},{"key":"R15-4-20210227","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0196-9781(02)00137-7","article-title":"Vasoactive intestinal peptide regulation of nerve growth factor in the embryonic mouse.","volume":"23","author":"Hill","year":"2002","journal-title":"Peptides"},{"key":"R16-4-20210227","first-page":"5177","article-title":"In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide.","volume":"50","author":"Pence","year":"1990","journal-title":"Cancer Res"},{"key":"R17-4-20210227","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/1097-0142(19921001)70:7<2005::AID-CNCR2820700733>3.0.CO;2-H","article-title":"Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors.","volume":"70","author":"Qualman","year":"1992","journal-title":"Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mph.0000139414.66455.a4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:26:25Z","timestamp":1785785185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200409000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mph.0000139414.66455.a4","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}